|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Cancer Institute (NCI) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001503 |
Purpose
This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.
| Condition |
|---|
|
Acquired Immunodeficiency Syndrome Neoplasm Skin Disease HIV Infections |
| Study Type: | Observational |
| Official Title: | Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols |
| Estimated Enrollment: | 1500 |
| Study Start Date: | May 1996 |
Background:
Patients enrolled on CCR clinical protocols may require long term follow-up to assess outcome (e.g., survival) or the effects of prior therapy.
Keeping the primary treatment protocols open after accrual is complete in order to follow patients for long term outcome is an administrative burden on investigators and the IRB.
Objectives:
To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol.
Eligibility:
Patients who were previously enrolled on a CCR protocol and who are not eligible for an active NCI intramural primary research protocol.
Design:
The medical procedures/tests will be based on the patient's diagnosis, treatment and supporting clinical information. This is a follow-up study in which only standard tests and procedures are to be performed.
Clinical information that is relevant to the patients prior protocols will be collected for research purposes.
Procedures that entail more than minimal risk to the patient should not be performed for research purposes on this protocol.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Patients of any age who were previously enrolled on a CCR protocol.
Not eligible for or unwilling to participate in an active NCI intramural primary research protocol.
CCR investigator decides it is in the best interests of the patient and the CC for the patient to be seen in follow-up visits at the NIH.
Patient or guardian is able to provide informed consent.
Contacts and Locations| Contact: NCI Referral Office | 1-888-NCI-1937 | |
| Contact: Caryn Steakley, R.N. | (301) 435-3685 | steaklec@mail.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Sub-Investigator: National Cancer Institute Referral Office For more information at the NIH Clinical Center contact | |
More Information
| ClinicalTrials.gov Identifier: | NCT00001503 History of Changes |
| Obsolete Identifiers: | NCT00296075 |
| Other Study ID Numbers: | 960071, 96-C-0071 |
| Study First Received: | November 3, 1999 |
| Last Updated: | December 30, 2011 |
| Health Authority: | United States: Federal Government |
|
Natural History Neutropenia Non-Therapeutic Chronic Effects Rare Diseases |
|
HIV Infections Acquired Immunodeficiency Syndrome Neoplasms Immunologic Deficiency Syndromes Skin Diseases Lentivirus Infections Retroviridae Infections |
RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immune System Diseases Slow Virus Diseases |
